SC 51089 free base,98.64%

产品编号:Bellancom-108563A| CAS NO:146033-03-6| 分子式:C22H19ClN4O3| 分子量:422.86

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,

货号 包装 价格 库存与货期 购买量 操作
Bellancom-108563A
1000.00 杭州 北京(现货)
Bellancom-108563A
1600.00 杭州 北京(现货)
Bellancom-108563A
3500.00 杭州 北京(现货)
Bellancom-108563A
6200.00 杭州 北京(现货)
Bellancom-108563A
10900.00 杭州 北京(现货)

增值税发票√顺丰快递√订货电话:18601927057

SC 51089 free base

产品介绍 SC 51089 free base 是一种选择性的前列腺素受体 EP1 拮抗剂,对 EP1TPEP3FP 受体的 Ki 值分别为 1.3,11.2,17.5 和 61.1 μM。SC 51089 free base 具有神经保护活性。
生物活性

SC 51089 free base is a selective antagonist of prostaglandin E2 EP1 receptor, with Kis of 1.3, 11.2, 17.5, and 61.1 μM for EP1, TP, EP3, and FP receptors, respectively. SC 51089 free base exhibits neuroprotective activity.

体外研究

SC 51089 free base (5 μM; 24 h) 减弱前列腺素 E2 (PGE2) 诱导的暴露于 t-BuOOH 的神经元细胞死亡

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究

SC 51089 free base (40 μg/kg; infused i.p. for 28 d) 改善 HD 小鼠运动协调和平衡功能障碍,并挽救长期记忆缺陷

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: R6/1 mouse model of Huntington's disease (HD), from 13 to 18 weeks of age
Dosage: 40 μg/kg/day
Administration: Infused i.p. at a rate of 0.11 μL/h during 28 days by osmotic mini-pump system
Result: Ameliorated motor coordination and balance dysfunction.
Rescued long-term memory deficit.
Improved the expression of specific synaptic markers.
Reduced the number of huntingtin nuclear inclusions in the striatum and hippocampus.
体内研究

SC 51089 free base (40 μg/kg; infused i.p. for 28 d) 改善 HD 小鼠运动协调和平衡功能障碍,并挽救长期记忆缺陷

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: R6/1 mouse model of Huntington's disease (HD), from 13 to 18 weeks of age
Dosage: 40 μg/kg/day
Administration: Infused i.p. at a rate of 0.11 μL/h during 28 days by osmotic mini-pump system
Result: Ameliorated motor coordination and balance dysfunction.
Rescued long-term memory deficit.
Improved the expression of specific synaptic markers.
Reduced the number of huntingtin nuclear inclusions in the striatum and hippocampus.
性状Solid
溶解性数据
In Vitro: 

DMSO : 100 mg/mL (236.48 mM; Need ultrasonic)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 2.3648 mL 11.8242 mL 23.6485 mL
5 mM 0.4730 mL 2.3648 mL 4.7297 mL
10 mM 0.2365 mL 1.1824 mL 2.3648 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)。-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, sealed storage, away from moisture and light

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)

参考文献

相关文档

化学品安全说明书(MSDS)

下载MSDS

质检证书(COA)

相关产品


服务热线

13911702513
18601927057

微信客服